KBKatherine J. Bangen

Katherine J. Bangen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Katherine J. Bangen has a total of 170 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Neuropsychological criteria for Mild Cognitive Impairment (MCI) best identify neuroimaging-based risk profiles: A Department of Defense/Alzheimer’s Disease Neuroimaging Initiative study

    by Anastasia Matchanova, Monica T. Ly, Conner Frank, Abigail Zaratan, Katherine J. Bangen, Mark W. Bondi, Lisa Delano-Wood

    Objectives: Few studies have examined how differing diagnostic criteria for mild cognitive impairment (MCI) relate to neuroimaging markers of cerebrovascular disease and neurodegeneration in Veterans. We compared three MCI diagnostic schemes on their associations with white matter hyperintensity (WMH) burden, hippocampal volume, and cortical thickness in nondemented Vietnam-era Veterans. Methods: 228 Veterans (mean age = 69.65) were classified using: (1) Alzheimer’s Disease Neuroimaging Initiative (ADNI) criteria (subjective memory concerns, impaired Logical Memory, global Clinical Dementia Rating = 0.5); (2) neuropsychological criteria (>1 standard deviation [SD] below norms on two tests within a domain or one test across three domains); and (3) typical criteria (subjective memory concerns and >1.5 SD below norms on one test). Regression models predicting WMH burden adjusted for age and intracranial volume and included MCI status and hippocampal volume; ADNI-based models also included posttraumatic stress disorder symptom severity. Results: Neuropsychological criteria were associated with greater WMH burden ( β = 0.45, p = .024), whereas typical and ADNI criteria were not. Sensitivity analyses found that meeting neuropsychological criteria for amnestic MCI interacted with lower hippocampal volume to predict greater WMH burden ( β = −0.001, p = .028). No criteria were associated with cortical thickness. Conclusions: Neuropsychological criteria more sensitively identified Veterans with greater WMH burden and demonstrated a small, hippocampal volume-dependent effect in amnestic MCI. These findings support the clinical utility of multi-test neuropsychological approaches for detecting complex brain changes in high-comorbidity populations, with implications for risk stratification and targeted intervention in aging Veterans.


  • Open Access

    Effects of age and APOE ϵ4 genotype on the relationship between pulse pressure and executive function in older adults without Dementia

    by Melanie L. Quiring, Lauren Edwards, Katherine J. Bangen, Emily H. Ho, Cynthia M. Carlsson, Douglas Galasko, Sandra Weintraub, Richard Gershon, David P. Salmon

    Objectives: Pulse pressure (PP) calculated as systolic minus diastolic blood pressure is a surrogate measure of arterial stiffness that may affect executive function; however, this relationship could be moderated by age and genetic risk for Alzheimer’s disease (AD). We therefore examined relationships among PP, age, AD risk (i.e., APOE genotype) and executive function measured by the NIH Toolbox Cognition Battery (NIHTB-CB) in older adults. Methods: PP was determined in 216 older adults without dementia (mean age: 77.5 ± 7.9 years, education: 16.8 ± 2.4 years, 55% women, 34.8% APOE ϵ4+) who were tested with the NIHTB-CB as part of the Advancing Reliable Measurement of Alzheimer’s Disease and Cognitive Aging (ARMADA) study. Results: Multiple linear regression revealed PP × Age × APOE genotype interaction effects for List Sorting Working Memory ( β = 0.04; p = .007) and Picture Sequence Memory ( β = 0.04; p = .006); higher PP was associated with worse scores in younger APOE ϵ4+ older adults (same pattern for fluid and total cognition composite scores). Higher PP was associated with lower Picture Vocabulary scores in ApoE ϵ4+ (PP X APOE interaction: β = −0.19; p = .022). Higher PP was associated with lower Flanker Inhibitory Control scores ( β = −0.13; p = .005) across all participants. Conclusions: Arterial stiffness measured by PP in older adults is associated with worse performance on NIHTB-CB tests of executive function, working memory, and episodic sequence memory, particularly in younger APOE ϵ4 carriers. Arterial stiffness and AD risk may work synergistically in an age dependent manner to adversely affect cognition.

  • Open Access

    Greater Cognitive Intraindividual Variability Predicts Faster Decline in Everyday Functioning: Moderating Effects of Amyloid Status and APOE Genotype

    by Katherine J. Bangen, Lauren C. Edwards, Fini Chang, Fareshte Erani, Caitlin M. Terao, Kelsey R. Thomas

    Background: Cognitive intraindividual variability (IIV), or within‐person variability across cognitive measures at a single time point, is associated with increased risk of mild cognitive impairment (MCI) and Alzheimer's disease (AD) dementia. We have previously shown that IIV is a sensitive marker of future declines in everyday functioning, but little is known about its role as a sensitive marker of risk for decline among specific groups, including individuals who are amyloid‐β (Aβ) positive or apolipoprotein E (APOE) ε4 carriers. Therefore, we investigated potential moderating effects of Aβ status and APOE genotype on the association between IIV and everyday functioning. Method: 736 Alzheimer's Disease Neuroimaging Initiative (ADNI) participants without dementia (341 Aβ+, 395 Aβ‐; 300 APOE ε4+, 436 APOE ε4‐) underwent neuropsychological testing including assessment of everyday functioning at baseline and annual follow‐up visits across two years. Florbetapir positron emission tomography (PET) imaging was used to measure Aβ deposition, and Aβ status (positive or negative) was determined based on established cutoffs. Everyday functioning was measured using the Functional Assessment Questionnaire (higher scores = greater difficulty). Linear mixed effects models adjusting for demographics, AD risk factors, and individual‐level mean cognitive performance, examined whether baseline IIV interacted with Aβ and APOE ε4 status on everyday functioning. Results: Higher baseline IIV predicted faster rate of decline in everyday functioning among Aβ+ relative to Aβ‐ participants (three‐way IIV x Aβ status x time interaction: b=0.13, 95% CI: [0.08, 0.17], p < .001) and among APOE ε4 carriers compared to non‐carriers (three‐way IIV x APOE ε4 status x time interaction: b=0.08, 95% CI: [0.03, 0.12], p < .001). Conclusion: Greater cognitive IIV was associated with faster functional decline, particularly among individuals who are Aβ+ or APOE ε4 carriers. Findings suggest that IIV may be a sensitive marker of brain changes and functional decline, offering added utility above and beyond conventional AD risk factors including age and gender as well as mean level of cognitive performance. Future research is needed to determine how to best operationalize IIV and establish reliability and validity of IIV in populations who better represent older adults who may be at greater risk for cognitive decline.

  • Open Access

    Interactive effects of blood–brain barrier breakdown and Alzheimer's disease biomarker status on cognitive decline in older adults without dementia

    by Lauren Edwards, Amanda I. Gonzalez, Kelsey R. Thomas, Denis S. Smirnov, Einat K. Brenner, Daniel A. Nation, Fini Chang, Kaj Blennow, David P. Salmon, Douglas Galasko, et al.

    INTRODUCTION: Some research suggests that blood–brain barrier (BBB) integrity is altered in Alzheimer's disease (AD). Few studies have examined markers of BBB integrity and their interactions with AD risk factors on multi‐domain cognition. METHODS: 83 older adults without dementia underwent lumbar puncture, apolipoprotein E (APOE) genotyping, and neuropsychological testing with up to 5 years of follow‐up. Soluble platelet‐derived growth factor receptor beta (sPDGFRβ) was measured in cerebrospinal fluid. RESULTS: Higher baseline sPDGFRβ was associated with better cross‐sectional attention, visuospatial, and executive functioning, but with steeper longitudinal decline in executive function. When considering AD risk status, higher sPDGFRβ was associated with faster longitudinal decline in all cognitive domains in biomarker‐positive relative to biomarker‐negative individuals and in language in APOE ɛ4‐positive relative to ɛ4‐negative individuals. DISCUSSION: Elevated sPDGFRβ may increase risk of cognitive decline, particularly in individuals with a higher risk for AD. Future studies should explore mechanisms that contribute to these relationships. Highlights: Cerebrospinal fluid (CSF) soluble platelet‐derived growth factor receptor beta (sPDGFRβ) is a promising marker of blood–brain barrier (BBB) integrity. Higher sPDGFRβ was cross‐sectionally associated with better cognition at baseline. Higher sPDGFRβ was longitudinally associated with steeper decline in cognition, particularly among amyloid beta (Aβ) 42/Aβ40+ individuals. CSF concentration of sPDGFRβ may predict cognitive decline in those with increased dementia risk.


  • Open Access

    Cognitive dispersion is associated with white matter hyperintensities in amyloid positive older adults

    by Daliah Ross, Fini Chang, Lauren Edwards, Kelsey R. Thomas, Katherine J. Bangen, For The Alzheimer’s Disease Neuroimaging Initiative

    Objective: White matter hyperintensities (WMH), imaging markers of small vessel cerebrovascular disease, are associated with risk of dementia, including Alzheimer's disease (AD). Cognitive intraindividual variability (IIV) has emerged as a sensitive measure of future decline. We examined associations between IIV-dispersion, beta-amyloid (Aß) positivity, and WMH in older adults. Method: We included 819 participants (mean age = 72.01) without dementia from the Alzheimer's Disease Neuroimaging Initiative. IIV-dispersion was calculated as the intraindividual standard deviation across 6 neuropsychological scores. WMH volume was quantified on T2-weighted fluid attenuated inversion recovery images. Regression models examined interactions between IIV-dispersion and Aß status on WMH, adjusting for age, sex, and education. Results: Amyloid status moderated associations between IIV-dispersion and WMH, such that higher IIV-dispersion was associated with greater WMH in Aß+ individuals whether WMH was examined as a continuous (B = 0.30, ß = 0.13, p = .006) or a dichotomous variable based on quartiles (odds ratio [OR] = 2.41, p < .001). Sensitivity analyses to adjust for the effects of individual mean cognition in the models modified findings such that greater IIV-dispersion was again associated with greater WMH in Aß+ individuals when WMH was examined dichotomously (OR = 2.13, p = .018) but the effect was attenuated for continuous WMH. Conclusions: Greater IIV-dispersion was associated with greater WMH among Aß+ individuals. IIV-dispersion may be an early marker of cerebrovascular changes in AD although future research is needed to further establish its incremental utility.


  • Open Access

    Interactive effects of arterial stiffness and Alzheimer's disease risk on cognitive decline in older adults without dementia

    by Lauren Edwards, Denis S. Smirnov, Kelsey R. Thomas, Katherine Longardner, Lisa Delano‐Wood, Mark W. Bondi, David P. Salmon, Douglas Galasko, Katherine J. Bangen

    INTRODUCTION: Among individuals who are amyloid biomarker–positive or apolipoprotein E ( APOE) ε4 carriers, arterial stiffness reflected by higher pulse wave velocity (PWV) has been associated with lower cognition cross‐sectionally. Less is known about longitudinal associations. METHODS: The sample included 152 older adults without dementia. Linear mixed‐effects models examined if PWV (1) was associated with cognitive decline and (2) interacted with APOE ɛ4 status or cerebrospinal fluid (CSF) amyloid positivity on cognitive decline. RESULTS: PWV was not associated with cognitive decline across any domains. There was an interaction between PWV and CSF amyloid positivity on executive function ( p = 0.038) and language ( p = 0.047), such that higher PWV was related to faster decline in CSF amyloid‐positive individuals relative to amyloid‐negative individuals. PWV did not interact with APOE ɛ4 status on cognitive decline. DISCUSSION: PVW, as a marker of vascular risk, may adversely modify the trajectory of cognitive decline, particularly in amyloid‐positive individuals. Highlights: Pulse wave velocity (PWV) was not associated with cognitive decline in any domain. Amyloid status moderated the effect of PWV on executive function and language decline. Higher PWV was associated with faster decline among amyloid‐positive individuals. There was no interaction between PWV and apolipoprotein E ( APOE ) ε4 status on cognitive decline.


  • Associations of cognitive intraindividual variability with Alzheimer’s disease risk: A systematic review

    by Fini Chang, Fareshte Erani, Daniel Landaverde, Caitlin M. Terao, Alexis Spence, Alyson Zabala, Thiri H. Aung, Jessica Wilde, Kelsey R. Thomas, Katherine J. Bangen

    Objective: Cognitive intraindividual variability (IIV) refers to an individual's variability in performance across cognitive measures and includes inconsistency and dispersion. While IIV has been studied in the context of cognitive aging, its application to Alzheimer's disease (AD) is more recent. This review synthesizes current research on IIV in AD risk, evaluating the role of IIV in distinguishing between cognitive stages and exploring associations with biomarkers to elucidate underlying mechanisms. Method: A systematic search strategy was employed across three electronic databases (PubMed, PsycINFO, and Web of Science) adhering to PRISMA guidelines. Forty-four studies met inclusion criteria and were included in the review. Results: Of the 44 reviewed articles, 19 examined inconsistency, 23 examined dispersion, and 2 studies examined both. Inconsistency-based studies broadly showed that greater IIV was associated with increased severity of cognitive impairment, particularly in mild cognitive impairment (MCI) and AD dementia. Findings of dispersion-based studies were mixed but largely revealed that higher IIV was associated with MCI and predicted incident dementia. Both IIV metrics suggested relationships between IIV and AD biomarkers (e.g. amyloidosis). Conclusions: Despite some variability in findings across studies, measures of inconsistency and dispersion are associated with cognitive impairment, cognitive decline, and AD biomarkers, even after adjusting for mean cognitive performance. The results expand upon prior studies, with more restrictive inclusion criteria, by including studies examining broad AD risk. There remains a lack of consensus on IIV assessment methods, complicating direct comparisons, but IIV measures have shown considerable potential for identifying individuals at risk of dementia.


  • Open Access

    Growth-associated protein 43 is associated with faster functional decline among amyloid-positive individuals with objectively defined subtle cognitive decline and mild cognitive impairment.

    by Amanda I. Gonzalez, Lauren C. Edwards, Kelsey R. Thomas, Alexandra J. Weigand, Maria Bordyug, Einat K. Brenner, Uriel A. Urias, Katherine J. Bangen

    Objectively defined subtle cognitive decline (Obj-SCD) is an emerging classification that may identify individuals at risk for future decline and progression to Alzheimer's disease prior to a diagnosis of mild cognitive impairment (MCI). Growth-associated protein 43 (GAP-43), a cerebrospinal fluid (CSF) marker of synaptic dysfunction, has been shown to relate to an increased risk of converting to dementia, although it is unclear whether GAP-43 alterations may be detected in pre-MCI stages. Therefore, in the present study, we examined CSF GAP-43 levels among individuals with Obj-SCD cross-sectionally and also examined whether baseline GAP-43 predicts future functional decline. Six hundred forty-four participants from the Alzheimer's Disease Neuroimaging Initiative were divided into six groups based on (a) cognitive status (cognitively unimpaired [CU], Obj-SCD, or MCI) and (b) Aβ status (+ or -). The CU- group had lower baseline GAP-43 than all Aβ+ groups, but not the other Aβ- groups. Higher GAP-43 levels were associated with faster decline across the entire sample. When moderation by group was examined, higher GAP-43 at baseline predicted faster functional decline for the Obj-SCD+ and MCI+ groups, compared to the CU- group. Results extend prior work investigating biomarker associations in Obj-SCD to GAP-43 and show that high baseline CSF GAP-43 is associated with a faster rate of functional decline in Aβ+ individuals who are classified as Obj-SCD or MCI. Importantly, our findings further demonstrate that CSF GAP-43 is associated with early and subtle cognitive changes detectable before the onset of MCI. (PsycInfo Database Record (c) 2025 APA, all rights reserved).


  • Open Access

    Interactive effects of post-traumatic stress disorder symptom severity and hypertension on cognitive dispersion in older Vietnam-Era veterans with history of post-traumatic stress disorder

    by Uriel A. Urias, Kelsey R. Thomas, Alexandra J. Weigand, Maria Bordyug, Amanda Gonzalez, Britney Luu, Alin Alshaheri Durazo, Mary Ellen Garcia, Katherine J. Bangen, for the Department of Defense Alzheimer’s Disease Neuroimaging Initiative

    Objective: Post-traumatic stress disorder (PTSD) and hypertension are highly prevalent among Veterans. Cognitive dispersion, indicating within-person variability across neuropsychological measures at one time point, is associated with increased risk of dementia. We examined interactive effects of PTSD symptom severity and hypertension on cognitive dispersion among older Veterans.Methods: We included 128 Vietnam-era Veterans from the Department of Defense-Alzheimer’s Disease Neuroimaging Initiative (DoD-ADNI) with a history of PTSD. Regression models examined interactions between PTSD symptom severity and hypertension on cognitive dispersion (defined as the intraindividual standard deviation across eight cognitive measures) adjusting for demographics and comorbid vascular risk factors.Results: There was an interaction between PTSD symptom severity and hypertension on cognitive dispersion (p = .026) but not on mean cognitive performance (p = .543). Greater PTSD symptom severity was associated with higher cognitive dispersion among those with hypertension (p = .002), but not among those without hypertension (p = .531). Results remained similar after adjusting for mean cognitive performance.Conclusions: Findings suggest, among older Veterans with PTSD, those with both hypertension and more severe PTSD symptoms may be at greater risk for cognitive difficulties. Further, cognitive dispersion may be a useful marker of subtle cognitive difficulties. Future research should examine these associations longitudinally and in a diverse sample.


  • Open Access

    Associations of Post-Traumatic Stress Disorder and Objective Subtle Cognitive Difficulties in Cognitively Unimpaired Older Veterans

    by Mary Ellen Garcia, Peter Rantins, Alin Alshaheri Durazo, Uriel Urias, Alexandra J Weigand, Katherine J Bangen, Mark W Bondi, Amy J Jak, Kelsey R Thomas

    Introduction: Psychiatric conditions such as post-traumatic stress disorder (PTSD) and depression have a two-fold increased dementia risk in Veterans. Prior work has shown that psychiatric factors can both impact cognitive functioning and be early symptoms associated with Alzheimer’s disease (AD). Objectively defined subtle cognitive difficulties (Obj-SCD) has been associated with cognitive decline and AD biomarkers. However, Obj-SCD has not yet been investigated in the context of psychiatric disorders. Methods: A total of 179 cognitively unimpaired Veterans (50–92 years old) underwent a comprehensive neuropsychological evaluation at VA San Diego and a retrospective medical record review. Chi-squared tests compared rates of psychiatric diagnoses in Veterans with and without Obj-SCD. Results: About 21% of the sample was classified as Obj-SCD. Relative to cognitively unimpaired Veterans, Veterans classified as Obj-SCD had higher rates of PTSD, but not higher rates of other psychiatric conditions (e.g., depression). The PTSD findings appear to be driven by measures of cognitive efficiency. Conclusion: Elevated rates of PTSD, but not other psychiatric conditions, were observed among Veterans with Obj-SCD. The prevalence and type of subtle cognitive difficulties associated with PTSD in older Veterans demonstrates a need, and informs potential targets, for intervention. Further work is needed to determine mechanisms of subtle cognitive difficulties in older Veterans with PTSD.